Skip to main content

Barbara Dudley Alexander

Professor of Medicine
Medicine, Infectious Diseases
Duke Box 102359, Durham, NC 27710
315 Trent Drive, Hanes House, Room 163A, Durham, NC 27710

Overview


Clinical research related to infectious complications of solid organ and bone marrow transplantation, with a particular interest in the treatment and rapid diagnosis of fungal disease. Training the next generation of Transplant Infectious Disease Physicians is a special focus of mine as the Principal Investigator of our Interdisciplinary T32 Training Program funded the NIH.

Current Duke Appointments & Affiliations


Professor of Medicine · 2014 - Present Medicine, Infectious Diseases, Medicine
Professor of Pathology · 2014 - Present Pathology, Clinical Science Departments

Recent Scholarly Works


Organ-specific differences in the epidemiology of cytomegalovirus infections in high-risk (cytomegalovirus donor seropositive, recipient seronegative) solid organ transplant recipients with prolonged follow-up: A 10-year experience.

Journal article Am J Transplant · March 26, 2026 Cytomegalovirus (CMV) causes significant morbidity in CMV donor seropositive/recipient seronegative (D+R-) solid organ transplant recipients, but organ-specific differences in CMV epidemiology and the utility of laboratory surveillance after prophylaxis (S ... Full text Link to item Cite

Fungal diagnostic stewardship in immunocompromised populations: a focus on molds and dimorphic fungi.

Journal article Clin Microbiol Rev · March 12, 2026 SUMMARYInvasive fungal diseases cause severe illness and death in immunocompromised patients. Antifungal use is increasingly common, as is fungal diagnostic testing. However, these efforts have not been guided by traditional stewardship efforts akin to tho ... Full text Link to item Cite

Olorofim in combination with azole antifungals: results from the Phase 2 salvage therapy study.

Journal article J Antimicrob Chemother · March 4, 2026 BACKGROUND: Olorofim is an antifungal agent with a novel mechanism of action against Aspergillus spp., rare moulds and dimorphic fungi. Preclinical studies reported unidirectional antagonism between olorofim and mould-active azoles (e.g. azoles other than ... Full text Link to item Cite
View All Scholarly Works

Recent Grants


Novel Host-Response Biomarker Diagnostics for Invasive Aspergillosis

ResearchCo-Mentor · Awarded by National Institute of Allergy and Infectious Diseases · 2024 - 2029

Tri-Institutional Molecular Mycology and Pathogenesis Training Program

Inst. Training Prgm or CMEMentor · Awarded by National Institute of Allergy and Infectious Diseases · 2024 - 2029

UAB - Clinical and Applied Research Strategies for the Prevention and Control of Fungal Diseases

ResearchPrincipal Investigator · Awarded by University of Alabama at Birmingham · 2023 - 2028

View All Grants

Education


East Carolina University · 1993 M.D.